You've been clearing your throat for months. Maybe years. Your voice is hoarse by afternoon. There's a lump that won't go away no matter how many times you swallow. You've got a dry cough that nobody can explain not your GP, not the allergist, not the ENT.

You've tried allergy meds. Inhalers. Nasal sprays. Antibiotics. Nothing touches it.

Here's what nobody told you: you don't have allergies. You don't have asthma. You have acid damage in your throat and you may not have a single symptom of heartburn.

This condition is called Laryngopharyngeal Reflux (LPR), also known as "silent reflux" or airway reflux. It affects up to 10% of the population, causes 50% of chronic hoarseness cases, and is one of the most misdiagnosed conditions in medicine [1].

If you've been bouncing between specialists without answers, this article will explain exactly what's happening in your body and what you can do about it.

This is the most important thing you'll read today: GERD and LPR have different damage sites, different mechanisms, and need different approaches [2].

GERD happens when acid refluxes into the lower esophagus. Your esophagus is built to handle some of this — it has protective mechanisms that can cope with up to 50 reflux episodes per day.

LPR happens when reflux travels higher — past the upper esophageal sphincter and into your larynx, pharynx, and airway. Your larynx has zero of those protective mechanisms. Research shows that as few as 3 reflux episodes can cause laryngeal damage [3].

That's why:

• 80% of GERD patients have heartburn — but only 20% of LPR patients do [4]
• 87% of LPR patients clear their throat constantly — but fewer than 5% of GERD patients do
• Your GI doctor may say your esophagus "looks fine" — because the damage is above where they're looking
• PPIs often don't work for LPR the way they work for GERD — because the problem isn't just acid

This is why you've been misdiagnosed. Your condition doesn't show up where GERD shows up.

Here's the biology that changes everything:

The main agent of damage in LPR isn't just acid — it's an enzyme called pepsin. Pepsin is produced in your stomach to break down protein. When it refluxes into your throat, it gets absorbed into your laryngeal tissue and stays there [5].

Even after the reflux episode is over. Even when there's no acid present. Pepsin sits inside your cells at a neutral pH, dormant but stable. The next time any acid reaches your throat — even from food, drink, or another mild reflux episode — that dormant pepsin reactivates and resumes destroying tissue from the inside [6].

This is why PPIs alone often fail for LPR patients:

• PPIs reduce acid production — but pepsin causes damage even in non-acid reflux
• PPIs don't remove pepsin that's already embedded in laryngeal tissue
• PPIs work on the stomach — they don't coat or protect the throat and upper esophagus
• LPR requires at least 6 months of treatment vs. 8 weeks for typical GERD [7]

As one study put it: LPR patients see an average of 10 specialists and undergo 6 tests in their first year alone — often without answers [8].

The Reflux Symptom Index (RSI) is a validated clinical tool for identifying LPR. If you score above 13, LPR is likely [9]. Rate each symptom 0–5 (no problem to severe):

• Hoarseness or voice problems — voice tired by afternoon, breaks mid-sentence, raspy
• Throat clearing — constant urge, worse after meals, feels like mucus you can't clear
• Excess throat mucus / post-nasal drip — thick, sticky, allergy meds don't help
• Difficulty swallowing — pills scraping, food feeling stuck, tightness
• Cough after eating or lying down — dry, persistent, inhalers useless
• Breathing difficulties / choking — catching breath, sensation of airway narrowing
• Annoying or troublesome cough — the one nobody can diagnose
• Lump in throat (globus) — constant presence, swallowing doesn't clear it
• Heartburn, chest pain, indigestion — present in only 20-35% of LPR patients

If you checked 3 or more of these, and heartburn is NOT your primary symptom, you are likely dealing with airway reflux — not classical GERD. And that changes everything about how it should be addressed.

Your esophagus has built-in defenses: carbonic anhydrase enzymes that neutralize acid, thick stratified squamous epithelium, and rapid peristalsis that clears refluxate.

Your larynx has none of these.

It's lined with delicate ciliated respiratory epithelium — the same type of tissue that lines your lungs. When pepsin reaches this tissue, it depletes the protective proteins (carbonic anhydrase III, E-cadherin) that maintain the barrier [10]. The result:

• The epithelial barrier breaks down → more pepsin gets absorbed
• Inflammatory pathways activate → swelling, redness, mucus production
• Vocal cord tissue thickens → hoarseness, voice fatigue
• Cough receptors sensitize → chronic cough that doesn't respond to typical treatments
• Globus sensation intensifies → the "lump" that won't go away

This is why your ENT sees inflammation but can't find an infection. This is why allergy meds don't work. The damage is chemical, not viral or allergic.

Here's the problem with every capsule or tablet for LPR: they skip past the tissue that needs help. Pills drop straight to the stomach. The throat, larynx, and upper esophagus — the exact sites where LPR causes damage — get zero contact with the active ingredients.

EsoRepair™ was designed differently. It's a liquid formula you sip slowly. As it moves down, nano-sized particles of soothing botanicals coat the entire esophageal and upper airway tract — including the regions where silent reflux does its damage [11].

This matters for LPR specifically because:

• Marshmallow root and slippery elm form a mucilage layer that physically coats irritated laryngeal tissue on contact
• Sodium alginate creates a "raft" above stomach contents — and research shows alginates also inhibit pepsin and bile salts, addressing the non-acid component of LPR [12]
• Hyaluronic acid forms a protective film over raw, pepsin-depleted tissue
• Zinc-L-Carnosine adheres to damaged tissue and supports integrity during oxidative stress

The delivery format IS the differentiator. For a condition that damages the throat, you need a formula that actually reaches the throat.

*Results based on published studies of individual ingredients. Doses/forms may differ. Individual results vary. Not intended to diagnose, treat, cure, or prevent any disease.

LPR takes longer to resolve than GERD — research recommends a minimum of 3-6 months of treatment [7]. EsoRepair™ is designed as a 90-day structured protocol:

Marshmallow root, slippery elm, and alginate begin coating upper esophageal and laryngeal tissue. Users report less throat clearing, smoother swallowing, and the "lump" starting to ease.

Hyaluronic acid, chondroitin sulfate, and glutamine support tissue maintenance in pepsin-depleted areas. Voice fatigue improves. Cough frequency decreases. Many users start trusting their voice again.

Aloe vera, DGL licorice, and quercetin support mucosal resilience and a healthy inflammatory response. Throat symptoms stabilize. The constant post-nasal drip sensation fades.

Your throat is functioning on a new baseline. Voice holds steady all day. The cough is quiet. The globus is gone. For many, this is the moment they realize the "allergy" they've had for years was never an allergy at all.

Backed by a 90-day money-back guarantee. If you don't see a meaningful difference, full refund.

"I don't have heartburn. Will this still help?"
EsoRepair™ was specifically designed to coat the upper esophageal and throat tissue — exactly where LPR causes damage. Most LPR patients don't have heartburn, and that's exactly why a liquid delivery format that contacts throat tissue directly matters more than any capsule.

"My ENT put me on a PPI. Can I use both?"
Yes. EsoRepair™ is designed to complement PPIs, not replace them. PPIs reduce acid production. EsoRepair™ coats and supports the tissue that's already been damaged. They address different parts of the problem.

"How long before I notice a difference?"
LPR tissue recovery is slower than GERD — clinical guidelines recommend 3-6 months of treatment. Most users report symptom improvement starting in weeks 2-4, with voice and cough improvements following by weeks 4-6.

"It's expensive."
$1.63/day on subscription. LPR patients spend an average of $5,438 in their first year on specialists and tests — often without improvement. The 90-day money-back guarantee means zero risk.

"I don't want a subscription."
Cancel anytime. No commitments. Start with a single bottle.

[1] Lechien JR, et al. Laryngopharyngeal reflux: a state-of-the-art algorithm management. StatPearls / Otolaryngol Head Neck Surg. 2023.
[2] PMC11056915. Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with GERD. World J Gastroenterol. 2024.
[3] Koufman JA. The otolaryngologic manifestations of GERD. Laryngoscope. 1991.
[4] Wikipedia / StatPearls — LPR: Heartburn in 20% of LPR vs 80% of GERD; throat clearing 87% in LPR vs <5% in GERD.
[5] Johnston N, et al. Pepsin is detected in laryngeal biopsies of LPR patients. Ann Otol Rhinol Laryngol. 2007.
[6] PMC4297018. Pepsin remains stable at pH 7.4 and reactivates upon acid exposure; intracellular pepsin causes cumulative tissue damage.
[7] Sung CK. Stanford LPR Protocol — minimum 6-month treatment, twice-daily PPI dosing required.
[8] PMC9012673. LPR patients see avg 10 specialists and undergo 6 tests in first year; $5,438/patient annual cost.
[9] Belafsky PC, et al. The Reflux Symptom Index (RSI). J Voice. 2002.
[10] Johnston N, et al. Pepsin depletes carbonic anhydrase III, E-cadherin, and Sep70 in laryngeal epithelium. Ann Otol Rhinol Laryngol. 2007.
[11] EsoRepair™ product formulation — liquid nano-delivery format designed for esophageal and upper airway tissue contact.
[12] PMC9012673. Alginates inhibit pepsin and bile salts; improve LPR symptoms as adjunct to PPI therapy.
[13] Fink C, et al. Marshmallow root extract for irritative cough. Complement Med Res. 2018.
[14] Hayashi K, et al. Polaprezinc protects against esophagitis. Int J Clin Oncol. 2016.
[15] Savarino V, et al. HA–chondroitin sulfate in NERD. Aliment Pharmacol Ther. 2017.